Berapakah harga Theradiag S.A. (ALTER)

Harga Theradiag S.A. (ALTER) adalah $1.38

Apakah topi pasaran Theradiag S.A. (ALTER)

Cap pasaran Theradiag S.A. (ALTER) adalah $12.52M

Theradiag S.A. (ALTER) Dividen

Theradiag S.A. specializes in the creation, production, and marketing of in-vitro diagnostic solutions. Its product line encompasses reagents for autoimmune conditions, IMMUNO-TROL — a comprehensive quality control tool with multiple parameters — and various instruments for testing both autoimmune disorders and infectious diseases. Among its unique offerings are the SQA-V system, engineered for semen analysis, and V-Sperm, a specialized application for digitally uploading and viewing sample results, including pictures and video recordings. The company's advanced instrumentation includes Theralis, which integrates multiplex FIDIS immunofluorescence with ELISA capabilities; Theralis µ, designed as a suitable solution for mid-sized laboratories; and the FIDIS platform, utilized for diverse laboratory analyses. Furthermore, Theradiag provides therapeutic drug monitoring services aimed at managing chronic inflammatory conditions. It also offers LISA tracker, an essential device for overseeing biotherapies, alongside both ELISA and rapid serological tests for SARS-CoV-2. Founded in 1986, Theradiag S.A. is based in Marne La Vallee, France.

Tahun	Dividen (diselaraskan untuk pemecahan saham)	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Dividen (diselaraskan untuk pemecahan saham)

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Tahun	Dividen	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Dividen

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Jumlah pembayaran dividen	Negara
Abbott Laboratories ABT.US	173.00%	US
Stryker Corporation SYK.US	85.00%	US
Medtronic plc MDT.US	178.00%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Edwards Lifesciences Corporation EW.US	0.00%	US

Syarikat

Jumlah pembayaran dividen

Negara